Industry Research Reports
Home > Reports > Service & Software > Global Bioanalytical and Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Bioanalytical and Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 172 Pages
Report ld: 4872416
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Bioanalytical and Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Clinical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Bioanalytical and Testing Services leading manufacturers including Eurofins Scientific, Charles River, LabCorp, Altasciences, Intertek, Celerion, ACM Global Laboratories, Q2 Solutions, WuXi AppTec, SGS, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bioanalytical and Testing Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Eurofins Scientific
- Charles River
- LabCorp
- Altasciences
- Intertek
- Celerion
- ACM Global Laboratories
- Q2 Solutions
- WuXi AppTec
- SGS
- Ardena
- VTT
- ICON
- Simbec-Orion
- Medpace
- Frontage
- Pharmaron
- Veeda
- GenScript
- Sino Biological
- Tigermed
- Medicilon
- Scinovo
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Small Molecule Bioanalysis
- Large Molecule Bioanalysis
- Biomarkers
- Biologics and Vaccines
Segment by Application
- Clinical
- Non-clinical
CHAPTER OUTLINE
Chapter 1: Defines the Bioanalytical and Testing Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Bioanalytical and Testing Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bioanalytical and Testing Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Small Molecule Bioanalysis
1.2.3 Large Molecule Bioanalysis
1.2.4 Biomarkers
1.2.5 Biologics and Vaccines
1.3 Market Segmentation by Application
1.3.1 Global Bioanalytical and Testing Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Non-clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bioanalytical and Testing Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Bioanalytical and Testing Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Bioanalytical and Testing Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Bioanalytical and Testing Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Small Molecule Bioanalysis Market Size by Players
3.3.2 Large Molecule Bioanalysis Market Size by Players
3.3.3 Biomarkers Market Size by Players
3.3.4 Biologics and Vaccines Market Size by Players
3.4 Global Bioanalytical and Testing Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bioanalytical and Testing Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bioanalytical and Testing Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Bioanalytical and Testing Services Market Size by Type (2020-2031)
6.4 North America Bioanalytical and Testing Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bioanalytical and Testing Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Bioanalytical and Testing Services Market Size by Type (2020-2031)
7.4 Europe Bioanalytical and Testing Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bioanalytical and Testing Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Bioanalytical and Testing Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Bioanalytical and Testing Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Bioanalytical and Testing Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Bioanalytical and Testing Services Market Size by Type (2020-2031)
9.4 Central and South America Bioanalytical and Testing Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bioanalytical and Testing Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Bioanalytical and Testing Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Bioanalytical and Testing Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bioanalytical and Testing Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Corporation Information
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Bioanalytical and Testing Services Product Features and Attributes
11.1.4 Eurofins Scientific Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Scientific Bioanalytical and Testing Services Revenue by Product in 2024
11.1.6 Eurofins Scientific Bioanalytical and Testing Services Revenue by Application in 2024
11.1.7 Eurofins Scientific Bioanalytical and Testing Services Revenue by Geographic Area in 2024
11.1.8 Eurofins Scientific Bioanalytical and Testing Services SWOT Analysis
11.1.9 Eurofins Scientific Recent Developments
11.2 Charles River
11.2.1 Charles River Corporation Information
11.2.2 Charles River Business Overview
11.2.3 Charles River Bioanalytical and Testing Services Product Features and Attributes
11.2.4 Charles River Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.2.5 Charles River Bioanalytical and Testing Services Revenue by Product in 2024
11.2.6 Charles River Bioanalytical and Testing Services Revenue by Application in 2024
11.2.7 Charles River Bioanalytical and Testing Services Revenue by Geographic Area in 2024
11.2.8 Charles River Bioanalytical and Testing Services SWOT Analysis
11.2.9 Charles River Recent Developments
11.3 LabCorp
11.3.1 LabCorp Corporation Information
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Bioanalytical and Testing Services Product Features and Attributes
11.3.4 LabCorp Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.3.5 LabCorp Bioanalytical and Testing Services Revenue by Product in 2024
11.3.6 LabCorp Bioanalytical and Testing Services Revenue by Application in 2024
11.3.7 LabCorp Bioanalytical and Testing Services Revenue by Geographic Area in 2024
11.3.8 LabCorp Bioanalytical and Testing Services SWOT Analysis
11.3.9 LabCorp Recent Developments
11.4 Altasciences
11.4.1 Altasciences Corporation Information
11.4.2 Altasciences Business Overview
11.4.3 Altasciences Bioanalytical and Testing Services Product Features and Attributes
11.4.4 Altasciences Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.4.5 Altasciences Bioanalytical and Testing Services Revenue by Product in 2024
11.4.6 Altasciences Bioanalytical and Testing Services Revenue by Application in 2024
11.4.7 Altasciences Bioanalytical and Testing Services Revenue by Geographic Area in 2024
11.4.8 Altasciences Bioanalytical and Testing Services SWOT Analysis
11.4.9 Altasciences Recent Developments
11.5 Intertek
11.5.1 Intertek Corporation Information
11.5.2 Intertek Business Overview
11.5.3 Intertek Bioanalytical and Testing Services Product Features and Attributes
11.5.4 Intertek Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.5.5 Intertek Bioanalytical and Testing Services Revenue by Product in 2024
11.5.6 Intertek Bioanalytical and Testing Services Revenue by Application in 2024
11.5.7 Intertek Bioanalytical and Testing Services Revenue by Geographic Area in 2024
11.5.8 Intertek Bioanalytical and Testing Services SWOT Analysis
11.5.9 Intertek Recent Developments
11.6 Celerion
11.6.1 Celerion Corporation Information
11.6.2 Celerion Business Overview
11.6.3 Celerion Bioanalytical and Testing Services Product Features and Attributes
11.6.4 Celerion Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.6.5 Celerion Recent Developments
11.7 ACM Global Laboratories
11.7.1 ACM Global Laboratories Corporation Information
11.7.2 ACM Global Laboratories Business Overview
11.7.3 ACM Global Laboratories Bioanalytical and Testing Services Product Features and Attributes
11.7.4 ACM Global Laboratories Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.7.5 ACM Global Laboratories Recent Developments
11.8 Q2 Solutions
11.8.1 Q2 Solutions Corporation Information
11.8.2 Q2 Solutions Business Overview
11.8.3 Q2 Solutions Bioanalytical and Testing Services Product Features and Attributes
11.8.4 Q2 Solutions Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.8.5 Q2 Solutions Recent Developments
11.9 WuXi AppTec
11.9.1 WuXi AppTec Corporation Information
11.9.2 WuXi AppTec Business Overview
11.9.3 WuXi AppTec Bioanalytical and Testing Services Product Features and Attributes
11.9.4 WuXi AppTec Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.9.5 WuXi AppTec Recent Developments
11.10 SGS
11.10.1 SGS Corporation Information
11.10.2 SGS Business Overview
11.10.3 SGS Bioanalytical and Testing Services Product Features and Attributes
11.10.4 SGS Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Ardena
11.11.1 Ardena Corporation Information
11.11.2 Ardena Business Overview
11.11.3 Ardena Bioanalytical and Testing Services Product Features and Attributes
11.11.4 Ardena Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.11.5 Ardena Recent Developments
11.12 VTT
11.12.1 VTT Corporation Information
11.12.2 VTT Business Overview
11.12.3 VTT Bioanalytical and Testing Services Product Features and Attributes
11.12.4 VTT Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.12.5 VTT Recent Developments
11.13 ICON
11.13.1 ICON Corporation Information
11.13.2 ICON Business Overview
11.13.3 ICON Bioanalytical and Testing Services Product Features and Attributes
11.13.4 ICON Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.13.5 ICON Recent Developments
11.14 Simbec-Orion
11.14.1 Simbec-Orion Corporation Information
11.14.2 Simbec-Orion Business Overview
11.14.3 Simbec-Orion Bioanalytical and Testing Services Product Features and Attributes
11.14.4 Simbec-Orion Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.14.5 Simbec-Orion Recent Developments
11.15 Medpace
11.15.1 Medpace Corporation Information
11.15.2 Medpace Business Overview
11.15.3 Medpace Bioanalytical and Testing Services Product Features and Attributes
11.15.4 Medpace Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.15.5 Medpace Recent Developments
11.16 Frontage
11.16.1 Frontage Corporation Information
11.16.2 Frontage Business Overview
11.16.3 Frontage Bioanalytical and Testing Services Product Features and Attributes
11.16.4 Frontage Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.16.5 Frontage Recent Developments
11.17 Pharmaron
11.17.1 Pharmaron Corporation Information
11.17.2 Pharmaron Business Overview
11.17.3 Pharmaron Bioanalytical and Testing Services Product Features and Attributes
11.17.4 Pharmaron Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.17.5 Pharmaron Recent Developments
11.18 Veeda
11.18.1 Veeda Corporation Information
11.18.2 Veeda Business Overview
11.18.3 Veeda Bioanalytical and Testing Services Product Features and Attributes
11.18.4 Veeda Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.18.5 Veeda Recent Developments
11.19 GenScript
11.19.1 GenScript Corporation Information
11.19.2 GenScript Business Overview
11.19.3 GenScript Bioanalytical and Testing Services Product Features and Attributes
11.19.4 GenScript Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.19.5 GenScript Recent Developments
11.20 Sino Biological
11.20.1 Sino Biological Corporation Information
11.20.2 Sino Biological Business Overview
11.20.3 Sino Biological Bioanalytical and Testing Services Product Features and Attributes
11.20.4 Sino Biological Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.20.5 Sino Biological Recent Developments
11.21 Tigermed
11.21.1 Tigermed Corporation Information
11.21.2 Tigermed Business Overview
11.21.3 Tigermed Bioanalytical and Testing Services Product Features and Attributes
11.21.4 Tigermed Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.21.5 Tigermed Recent Developments
11.22 Medicilon
11.22.1 Medicilon Corporation Information
11.22.2 Medicilon Business Overview
11.22.3 Medicilon Bioanalytical and Testing Services Product Features and Attributes
11.22.4 Medicilon Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.22.5 Medicilon Recent Developments
11.23 Scinovo
11.23.1 Scinovo Corporation Information
11.23.2 Scinovo Business Overview
11.23.3 Scinovo Bioanalytical and Testing Services Product Features and Attributes
11.23.4 Scinovo Bioanalytical and Testing Services Revenue and Gross Margin (2020-2025)
11.23.5 Scinovo Recent Developments
12 Bioanalytical and Testing ServicesIndustry Chain Analysis
12.1 Bioanalytical and Testing Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bioanalytical and Testing Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bioanalytical and Testing Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Bioanalytical and Testing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Bioanalytical and Testing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Bioanalytical and Testing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Bioanalytical and Testing Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Bioanalytical and Testing Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Bioanalytical and Testing Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Bioanalytical and Testing Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Bioanalytical and Testing Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioanalytical and Testing Services as of 2024)
Table 11. Global Bioanalytical and Testing Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Bioanalytical and Testing Services Companies Headquarters
Table 13. Global Bioanalytical and Testing Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Bioanalytical and Testing Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Bioanalytical and Testing Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Bioanalytical and Testing Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Bioanalytical and Testing Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Bioanalytical and Testing Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Bioanalytical and Testing Services Growth Accelerators and Market Barriers
Table 25. North America Bioanalytical and Testing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Bioanalytical and Testing Services Growth Accelerators and Market Barriers
Table 27. Europe Bioanalytical and Testing Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Bioanalytical and Testing Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Bioanalytical and Testing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Bioanalytical and Testing Services Investment Opportunities and Key Challenges
Table 31. Central and South America Bioanalytical and Testing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Bioanalytical and Testing Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Bioanalytical and Testing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Eurofins Scientific Corporation Information
Table 35. Eurofins Scientific Description and Major Businesses
Table 36. Eurofins Scientific Product Features and Attributes
Table 37. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Eurofins Scientific Revenue Proportion by Product in 2024
Table 39. Eurofins Scientific Revenue Proportion by Application in 2024
Table 40. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Eurofins Scientific Bioanalytical and Testing Services SWOT Analysis
Table 42. Eurofins Scientific Recent Developments
Table 43. Charles River Corporation Information
Table 44. Charles River Description and Major Businesses
Table 45. Charles River Product Features and Attributes
Table 46. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Charles River Revenue Proportion by Product in 2024
Table 48. Charles River Revenue Proportion by Application in 2024
Table 49. Charles River Revenue Proportion by Geographic Area in 2024
Table 50. Charles River Bioanalytical and Testing Services SWOT Analysis
Table 51. Charles River Recent Developments
Table 52. LabCorp Corporation Information
Table 53. LabCorp Description and Major Businesses
Table 54. LabCorp Product Features and Attributes
Table 55. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. LabCorp Revenue Proportion by Product in 2024
Table 57. LabCorp Revenue Proportion by Application in 2024
Table 58. LabCorp Revenue Proportion by Geographic Area in 2024
Table 59. LabCorp Bioanalytical and Testing Services SWOT Analysis
Table 60. LabCorp Recent Developments
Table 61. Altasciences Corporation Information
Table 62. Altasciences Description and Major Businesses
Table 63. Altasciences Product Features and Attributes
Table 64. Altasciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Altasciences Revenue Proportion by Product in 2024
Table 66. Altasciences Revenue Proportion by Application in 2024
Table 67. Altasciences Revenue Proportion by Geographic Area in 2024
Table 68. Altasciences Bioanalytical and Testing Services SWOT Analysis
Table 69. Altasciences Recent Developments
Table 70. Intertek Corporation Information
Table 71. Intertek Description and Major Businesses
Table 72. Intertek Product Features and Attributes
Table 73. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Intertek Revenue Proportion by Product in 2024
Table 75. Intertek Revenue Proportion by Application in 2024
Table 76. Intertek Revenue Proportion by Geographic Area in 2024
Table 77. Intertek Bioanalytical and Testing Services SWOT Analysis
Table 78. Intertek Recent Developments
Table 79. Celerion Corporation Information
Table 80. Celerion Description and Major Businesses
Table 81. Celerion Product Features and Attributes
Table 82. Celerion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Celerion Recent Developments
Table 84. ACM Global Laboratories Corporation Information
Table 85. ACM Global Laboratories Description and Major Businesses
Table 86. ACM Global Laboratories Product Features and Attributes
Table 87. ACM Global Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. ACM Global Laboratories Recent Developments
Table 89. Q2 Solutions Corporation Information
Table 90. Q2 Solutions Description and Major Businesses
Table 91. Q2 Solutions Product Features and Attributes
Table 92. Q2 Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Q2 Solutions Recent Developments
Table 94. WuXi AppTec Corporation Information
Table 95. WuXi AppTec Description and Major Businesses
Table 96. WuXi AppTec Product Features and Attributes
Table 97. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. WuXi AppTec Recent Developments
Table 99. SGS Corporation Information
Table 100. SGS Description and Major Businesses
Table 101. SGS Product Features and Attributes
Table 102. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. SGS Recent Developments
Table 104. Ardena Corporation Information
Table 105. Ardena Description and Major Businesses
Table 106. Ardena Product Features and Attributes
Table 107. Ardena Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Ardena Recent Developments
Table 109. VTT Corporation Information
Table 110. VTT Description and Major Businesses
Table 111. VTT Product Features and Attributes
Table 112. VTT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. VTT Recent Developments
Table 114. ICON Corporation Information
Table 115. ICON Description and Major Businesses
Table 116. ICON Product Features and Attributes
Table 117. ICON Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. ICON Recent Developments
Table 119. Simbec-Orion Corporation Information
Table 120. Simbec-Orion Description and Major Businesses
Table 121. Simbec-Orion Product Features and Attributes
Table 122. Simbec-Orion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Simbec-Orion Recent Developments
Table 124. Medpace Corporation Information
Table 125. Medpace Description and Major Businesses
Table 126. Medpace Product Features and Attributes
Table 127. Medpace Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Medpace Recent Developments
Table 129. Frontage Corporation Information
Table 130. Frontage Description and Major Businesses
Table 131. Frontage Product Features and Attributes
Table 132. Frontage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Frontage Recent Developments
Table 134. Pharmaron Corporation Information
Table 135. Pharmaron Description and Major Businesses
Table 136. Pharmaron Product Features and Attributes
Table 137. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Pharmaron Recent Developments
Table 139. Veeda Corporation Information
Table 140. Veeda Description and Major Businesses
Table 141. Veeda Product Features and Attributes
Table 142. Veeda Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Veeda Recent Developments
Table 144. GenScript Corporation Information
Table 145. GenScript Description and Major Businesses
Table 146. GenScript Product Features and Attributes
Table 147. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. GenScript Recent Developments
Table 149. Sino Biological Corporation Information
Table 150. Sino Biological Description and Major Businesses
Table 151. Sino Biological Product Features and Attributes
Table 152. Sino Biological Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Sino Biological Recent Developments
Table 154. Tigermed Corporation Information
Table 155. Tigermed Description and Major Businesses
Table 156. Tigermed Product Features and Attributes
Table 157. Tigermed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Tigermed Recent Developments
Table 159. Medicilon Corporation Information
Table 160. Medicilon Description and Major Businesses
Table 161. Medicilon Product Features and Attributes
Table 162. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Medicilon Recent Developments
Table 164. Scinovo Corporation Information
Table 165. Scinovo Description and Major Businesses
Table 166. Scinovo Product Features and Attributes
Table 167. Scinovo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. Scinovo Recent Developments
Table 169. Raw Materials Key Suppliers
Table 170. Distributors List
Table 171. Market Trends and Market Evolution
Table 172. Market Drivers and Opportunities
Table 173. Market Challenges, Risks, and Restraints
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Bioanalytical and Testing Services Product Picture
Figure 2. Global Bioanalytical and Testing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Small Molecule Bioanalysis Product Picture
Figure 4. Large Molecule Bioanalysis Product Picture
Figure 5. Biomarkers Product Picture
Figure 6. Biologics and Vaccines Product Picture
Figure 7. Global Bioanalytical and Testing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Clinical
Figure 9. Non-clinical
Figure 10. Bioanalytical and Testing Services Report Years Considered
Figure 11. Global Bioanalytical and Testing Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 13. Global Bioanalytical and Testing Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Bioanalytical and Testing Services Revenue Market Share by Region (2020-2031)
Figure 15. Global Bioanalytical and Testing Services Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Small Molecule Bioanalysis Revenue Market Share by Player in 2024
Figure 18. Large Molecule Bioanalysis Revenue Market Share by Player in 2024
Figure 19. Biomarkers Revenue Market Share by Player in 2024
Figure 20. Biologics and Vaccines Revenue Market Share by Player in 2024
Figure 21. Global Bioanalytical and Testing Services Revenue Market Share by Type (2020-2031)
Figure 22. Global Bioanalytical and Testing Services Revenue Market Share by Application (2020-2031)
Figure 23. North America Bioanalytical and Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Bioanalytical and Testing Services Revenue (US$ Million) in 2024
Figure 25. North America Bioanalytical and Testing Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Bioanalytical and Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Bioanalytical and Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Bioanalytical and Testing Services Revenue (US$ Million) in 2024
Figure 32. Europe Bioanalytical and Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Bioanalytical and Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 35. France Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Bioanalytical and Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Bioanalytical and Testing Services Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Bioanalytical and Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Bioanalytical and Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 47. India Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Bioanalytical and Testing Services Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Bioanalytical and Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Bioanalytical and Testing Services Revenue (US$ Million) in 2024
Figure 55. Central and South America Bioanalytical and Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Bioanalytical and Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Bioanalytical and Testing Services Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Bioanalytical and Testing Services Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Bioanalytical and Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Bioanalytical and Testing Services Revenue (US$ Million) in 2024
Figure 61. South America Bioanalytical and Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Bioanalytical and Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Bioanalytical and Testing Services Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Bioanalytical and Testing Services Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Bioanalytical and Testing Services Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Bioanalytical and Testing Services Revenue (2020-2025) & (US$ Million)
Figure 67. Bioanalytical and Testing Services Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Bioanalytical and Testing Services market?
The top companies in the global Bioanalytical and Testing Services market are Eurofins Scientific、Charles River、LabCorp.
Related Reports
Global Bioanalytical and Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bioanalytical and Testing Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 164
USD 4900.00
(Single User License)
Global Bioanalytical and Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bioanalytical and Testing Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 117
USD 4250.00
(Single User License)
Bioanalytical and Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bioanalytical and Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 147
USD 3950.00
(Single User License)
Global Bioanalytical and Testing Services Market Research Report 2026
The global Bioanalytical and Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 160
USD 2900.00
(Single User License)
Global Bioanalytical and Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bioanalytical and Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 112
USD 4250.00
(Single User License)
Bioanalytical and Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bioanalytical and Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 158
USD 3950.00
(Single User License)
Global Bioanalytical and Testing Services Market Research Report 2025
The global market for Bioanalytical and Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 103
USD 2900.00
(Single User License)
Global Bioanalytical and Testing Services Market Research Report 2024
The global Bioanalytical and Testing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-07-07
Pages: 108
USD 2900.00
(Single User License)
Global and United States Bioanalytical and Testing Services Market Report & Forecast 2024-2030
The global Bioanalytical and Testing Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-07
Pages: 147
USD 4350.00
(Single User License)
Global Bioanalytical and Testing Services Market Insights, Forecast to 2030
The global Bioanalytical and Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-07-07
Pages: 163
USD 4900.00
(Single User License)
Global Bioanalytical and Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Bioanalytical and Testing Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 164
USD 4900.00 (Single User License)Global Bioanalytical and Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Bioanalytical and Testing Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 117
USD 4250.00 (Single User License)Bioanalytical and Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Bioanalytical and Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 147
USD 3950.00 (Single User License)Global Bioanalytical and Testing Services Market Research Report 2026
The global Bioanalytical and Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 160
USD 2900.00 (Single User License)Global Bioanalytical and Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Bioanalytical and Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 112
USD 4250.00 (Single User License)Bioanalytical and Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Bioanalytical and Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 158
USD 3950.00 (Single User License)Global Bioanalytical and Testing Services Market Research Report 2025
The global market for Bioanalytical and Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 103
USD 2900.00 (Single User License)Global Bioanalytical and Testing Services Market Research Report 2024
The global Bioanalytical and Testing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-07-07
Pages: 108
USD 2900.00 (Single User License)Global and United States Bioanalytical and Testing Services Market Report & Forecast 2024-2030
The global Bioanalytical and Testing Services revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-07
Pages: 147
USD 4350.00 (Single User License)Global Bioanalytical and Testing Services Market Insights, Forecast to 2030
The global Bioanalytical and Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-07-07
Pages: 163
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now